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ARTICLE
Spermine synthase and MYC cooperate to
maintain colorectal cancer cell survival by
repressing Bim expression
Yubin Guo1,2, Qing Ye2,3, Pan Deng 4, Yanan Cao2,3, Daheng He2, Zhaohe Zhou2, Chi Wang2,5,
Yekaterina Y. Zaytseva 2,6, Charles E. Schwartz 7, Eun Y. Lee2,8, B. Mark Evers 2,9, Andrew J. Morris 10,
Side Liu1✉ & Qing-Bai She 2,3✉
Dysregulation of polyamine metabolism has been linked to the development of colorectal
cancer (CRC), but the underlying mechanism is incompletely characterized. Here, we report
that spermine synthase (SMS), a polyamine biosynthetic enzyme, is overexpressed in CRC.
Targeted disruption of SMS in CRC cells results in spermidine accumulation, which inhibits
FOXO3a acetylation and allows subsequent translocation to the nucleus to transcriptionally
induce expression of the proapoptotic protein Bim. However, this induction is blunted by
MYC-driven expression of miR-19a and miR-19b that repress Bim production. Pharmacolo-
gical or genetic inhibition of MYC activity in SMS-depleted CRC cells dramatically induces
Bim expression and apoptosis and causes tumor regression, but these effects are profoundly
attenuated by silencing Bim. These findings uncover a key survival signal in CRC through
convergent repression of Bim expression by distinct SMS- and MYC-mediated signaling
pathways. Thus, combined inhibition of SMS and MYC signaling may be an effective therapy
for CRC.
https://doi.org/10.1038/s41467-020-17067-x OPEN
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Polyamines, including putrescine, spermidine, and spermine,are small polycationic metabolites that play a central role incell growth1,2. Ornithine decarboxylase (ODC) encoded by
ODC1 gene is the rate-limiting step in polyamine biosynthesis
and produces putrescine from ornithine1. Subsequently, putres-
cine is converted to spermidine and then spermine by two specific
aminopropyltransferases, spermidine synthase (SRM), and sper-
mine synthase (SMS), respectively (Fig. 1a). The aminopropyl
donor for these reactions is decarboxylated S-adenosylmethionine
(dcSAM), produced by S-adenosylmethionine decarboxylase
(SAMDC) encoded by AMD1 gene. The intracellular concentra-
tions of polyamines are maintained within a narrow range
through regulation of de novo synthesis, catabolism, and trans-
portation. Alterations in polyamine levels have been associated
with a variety of diseases, including neurodegeneration and
cancer1,3. Mutations in human SMS have been found to cause the
X-linked intellectual disability Synder-Robinson syndrome (SRS)
with the pathological spermidine accumulation in SRS patients4–
6. In cancer, polyamine metabolism is frequently dysregulated
primarily through upregulation of the polyamine biosynthetic
enzymes, which leads to elevated polyamine levels that are
necessary for malignant transformation and tumor progression1,2.
Thus, the polyamine metabolic pathway is an attractive target for
anticancer therapies.
Numerous inhibitors that target polyamine biosynthetic and
catabolic enzymes as well as polyamine transport have been
developed and tested in preclinical and clinical studies1. Despite
the early promise in vitro and several preclinical models of
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Fig. 1 SMS is overexpressed in CRC. a Schematics of polyamine metabolism pathway. ODC ornithine decarboxylase, SRM spermidine synthase, SMS
spermine synthase, SAMDC S-adenosylmethionine decarboxylase, SAM S-adenosylmethionine, dcSAM decarboxylated S-adenosylmethionine, MTA 5′-
methylthioadenosine. b–d The mRNA expression levels of SMS were analyzed from three different datasets of human CRC specimens. Statistical
significance between CRC tissues and normal controls was determined by the linear mixed model in b and d, or two-tailed two-sample t test in c, with the
p-values indicated. e, f A tissue microarray containing 57 pairs of human CRC tumor and adjacent normal control tissues was subjected to IHC staining for
SMS. Representative staining images are shown in e, and the percentages of the immunoreactivity scores are summarized in a diagram (f). Statistical
significance was determined by the χ2-test with the p-value indicated. Scale bar, 100 µm. g, h Matched normal and tumor tissues from six patients with
CRC were analyzed for SMS expression using western blot analysis (g). The expression of SMS protein was quantified by normalizing to β-actin using
Image J. The relative SMS levels in tumor tissues (h) were compared with that of normal tissues within the same patient. The data are presented as mean
values ±SEM (n= 6 biologically independent samples). The p-value by two-tailed unpaired t test is indicated. Source data are provided as a Source
Data file.
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cancer, clinical trials using single agents targeting the polyamine
pathway have generally proven to be disappointing1, except for
difluoromethylornithine (DFMO), an irreversible inhibitor of
ODC, which shows a single notable success in the treatment of
anaplastic gliomas7. DFMO exhibits encouraging efficacy in
ongoing clinical trials for neuroblastoma8 and prevention of
colorectal cancer (CRC) by combination with sulindac9. Never-
theless, DFMO treatment is generally thought to exert a cyto-
static, rather than a cytotoxic, effect, mainly due to the activation
of compensatory mechanisms that result in increased polyamine
transport or upregulation of SAMDC1,10.
Polyamine biosynthesis is promoted by multiple oncogenic
signaling pathways derived from many prevalent mutations in
cancers, including RAS, PI3K, and MYC2. These oncogenic
events frequently occur in CRC11. Recent studies on metabolic
changes and gene expression in CRC identify polyamines as
among the most altered metabolic pathways and reveals an
association between polyamine synthesis and tumorigenesis12,13.
Polyamine synthesis is heavily regulated by the pluripotent
transcription factor MYC at multiple levels. MYC increases
expression of many polyamine synthesis genes, including ODC1,
SRM, and AMD1, resulting an increase in the level of spermi-
dine14–16. Spermidine has been shown to be important for MYC
expression, cell proliferation, and malignant transformation17,18.
However, in contrast to the carcinogenic properties of poly-
amines, excessive accumulation of polyamines including sper-
midine can be cytotoxic independent of their oxidative
metabolites and facilitate the process of apoptosis in response to
death stimuli19,20. Together, these studies indicate an important
interplay between polyamine synthesis and oncogenic signaling.
How cancer cells maintain a relatively high level of polyamines
but below the toxic threshold to facilitate tumorigenesis is not
well understood.
In this study, we report that SMS is highly expressed in CRC.
Disruption of the SMS gene in CRC cells alters polyamine
metabolism by dramatically reducing the levels of spermine and
putrescine but producing excessive levels of spermidine. Our
mechanistic studies indicate that overexpression of SMS is
required for balancing spermidine levels to facilitate CRC cell
growth. Furthermore, our work demonstrates that SMS coop-
erates with MYC to maintain CRC cell survival via distinct
pathways that converge to repress expression of the proapoptotic
protein Bim. Combined inhibition of SMS and MYC signaling
induces synergistic apoptosis and tumor regression. This is,
therefore, a promising strategy for CRC therapy.
Results
SMS is overexpressed in CRC. To determine if SMS expression is
altered in CRC patients, we performed bioinformatic analysis of
three different microarray datasets from human CRC specimens.
SMS gene expression level was significantly increased in CRC
specimens as compared with normal controls (Fig. 1b–d). Inter-
estingly, additional analysis of SMS expression in patients with
stage I–IV CRC revealed that SMS expression was upregulated
upon tumor initiation when compared with normal controls, but
no further increase of SMS expression was observed as tumors
progressed through stage II–IV (Supplementary Fig. 1a). These
data suggest that the increase of SMS expression is an early event
in tumorigenesis. In addition, quantitative results obtained from
immunohistochemical (IHC) staining of a tissue microarray with
57 pairs of human CRC tumors and adjacent normal control
tissues also showed that SMS was overexpressed in CRC (Fig. 1e,
f), which even occurred at the early stage of CRC (Supplementary
Fig. 1b). Furthermore, we analyzed SMS protein expression in
matched normal and tumor tissues obtained from six patients
with CRC using western blot analysis. Consistent with IHC
staining results, SMS protein levels were elevated by almost
twofold in tumor tissues compared with normal controls (Fig. 1g,
h; Supplementary Fig. 1c). Collectively, these data provide evi-
dence that upregulation of SMS is associated with and may be
required for CRC tumorigenesis.
SMS deletion inhibits CRC cell growth. To define the role of
SMS in CRC tumorigenesis, we first used short hairpin RNAs
(shRNAs) to stably knock down SMS expression in HCT116
CRC cells (Supplementary Fig. 2a). Silencing SMS significantly
inhibited HCT116 cell growth in both 2D and 3D cell culture
conditions (Supplementary Fig. 2b–d). To further validate the
role of SMS in CRC cell growth, we generated SMS knockout
(KO) HCT116 and DLD-1 CRC cell lines using the CRISPR-
Cas9 system21. Sequencing results confirmed that four types of
frameshift indels were created in the targeted region of SMS exon
5 in these KO cells, but not in the wild-type (WT) cells (Sup-
plementary Fig. 3a). Consistent with shRNA-mediated SMS
knockdown, disruption of SMS also markedly inhibited the
growth of HCT116 and DLD-1 cells from two different SMS-KO
clones in both 2D and 3D cell culture conditions (Fig. 2a–e).
Similar results were observed in three additional SMS-KO
HCT116 or DLD-1 cell clones compared with their three addi-
tional SMS-WT cell clones (Supplementary Fig. 3b–d). To
determine whether inhibition of CRC cell growth by disruption
of SMS is mediated by an alteration in polyamine biosynthesis,
cellular polyamine levels were measured by liquid chromato-
graphy mass spectrometry (LC-MS). Spermine levels were not
detectable in both SMS-KO HCT116 and SMS-KO DLD-1 cells,
and levels of the upstream polyamine putrescine were also
drastically decreased (Fig. 2f). In contrast, spermidine levels were
increased by more than twofold in SMS-KO cells compared with
SMS-WT cells (Fig. 2f), while the levels of N1-acetylspermidine
(Fig. 1a), the limiting derivative in polyamine catabolism22, were
unaffected (Supplementary Fig. 4a). Since both SRM and SMS
use dcSAM as a common aminopropyl donor to produce sper-
midine from putrescine and spermine from spermidine, respec-
tively (Fig. 1a), the activities of SRM and SMS are limited by the
availability of dcSAM and hence, the activity of SAMDC23.
Similar to the reported increase in the activity and/or expression
of SAMDC by SMS loss-of-function in several models24,25, a
profound increase in SAMDC expression was observed in both
SMS-KO HCT116 and SMS-KO DLD-1 cells (Supplementary
Fig. 4b). Thus, the observed spermidine accumulation and
putrescine reduction in SMS-KO CRC cells is likely attributed to
the increased availability of dcSAM by SAMDC for spermidine
biosynthesis in the absence of SMS activity. Notably, exogenously
addition of putrescine and spermine in SMS-KO HCT116 cells to
the levels similar to those detected in SMS-WT HCT116 cells did
not alter spermidine accumulation or rescue cell growth inhibi-
tion by SMS deletion in both 2D and 3D cell culture conditions
(Fig. 2f, g; Supplementary Fig. 4c–e), excluding a significant
involvement of these polyamines in the SMS-KO cell growth. By
contrast, addition of exogenous spermidine to the SMS-WT
HCT116 cells resulted in a concentration-dependent growth
inhibition associated with a correlated increase in the intracel-
lular levels of spermidine (Fig. 2h; Supplementary Fig. 4f). Fur-
thermore, re-expression of SMS in the SMS-KO HCT116 cells,
which resulted in decreased spermidine level and restoration of
putrescine and spermine to the level similar to those observed in
the SMS-WT cells, could significantly reverse cell growth inhi-
bition by SMS deletion (Fig. 2f, i–k). Taken together, these data
indicate that SMS deletion-induced CRC cell growth inhibition is
mainly attributed to the accumulation of spermidine.
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SMS deletion sensitizes CRC cells to MYC repression by JQ1.
Polyamines play an important role in the regulation of cell-cycle
progression or apoptosis depending on other environmental
signals10,19,20. We first investigated the effect of SMS deletion on
cell-cycle progression and survival. Flow cytometry analysis
revealed no significant difference in the distribution of cell-cycle
phases and the induction of apoptosis between multiple SMS-WT
and SMS-KO individual clones generated from both HCT116 and
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Fig. 2 SMS knockout inhibits CRC cell growth associated with spermidine accumulation. a Cells from two SMS knockout (KO) HCT116 or DLD-1 clones,
and their control wild-type (WT) cells were analyzed by western blot for the indicated proteins. b, c SMS-WT or SMS-KO HCT116 (b) and DLD-1 (c) cells
were assessed for cell growth over 3 days. d Representative phase-contrast images of SMS-WT or SMS-KO HCT116 and DLD-1 cells cultured in 3D
Matrigel for 4 days. Scale bar, 100 µm. e The diameter of 50 randomly chosen spheroids as shown in d were measured. f The levels of putrescine (PUT),
spermidine (SPD), and spermine (SPM) in SMS-WT or SMS-KO HCT116 and DLD-1 cells were determined by LC-MS. g SMS-KO HCT116 cells were treated
with 1 mM putrescine or 20 µM spermine for 3 days, following by counting the number of viable cells. h HCT116 cells treated with the indicated
concentrations of spermidine were assessed for cell growth over 3 days. Results are expressed as a percentage of cell number relative to values obtained in
the control cells. i, j SMS-KO HCT116 cells with re-expression of SMS or vector control were analyzed by western blot (i) for the indicated proteins, or by
LC-MS analysis (j) for the levels of PUT, SPD, and SPM. k SMS-KO HCT116 cells with re-expression of SMS or vector control were assessed for cell growth
over 3 days. All graphic data are presented as mean values ±SEM (n= 3 independent experiments in b, c, e–h, j and k; n= 50 spheroids in d). The indicated
p-values were determined by two-tailed unpaired t test. Source data are provided as a Source Data file.
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DLD-1 cells (Supplementary Fig. 5a–c). Similar results were
observed in the mixed stable shRNA-mediated SMS knockdown
HCT116 cell populations compared with their control cell
populations (Supplementary Fig. 5d, e). Furthermore, addition of
exogenous spermidine to the SMS-WT HCT116 cells to mimic
spermidine accumulation seen in SMS-KO HCT116 cells, had
also no effect on cell-cycle progression and survival (Supple-
mentary Figs. 4f and 5f, g). These data suggest that the effect of
SMS deletion with spermidine accumulation on CRC cell growth
is regulated by other biological processes. MYC is activated in
nearly all CRC11 and involved in the regulation of polyamine
biosynthesis1,2. Similar to SMS expression, MYC was also over-
expressed in all stages of CRC (Supplementary Fig. 6a). Inter-
estingly, MYC expression showed a significant positive
correlation with SMS expression in CRC (Supplementary Fig. 6b),
which suggests a potential collaborative link between MYC and
SMS in maintaining or promoting CRC tumorigenesis. The
small-molecule JQ1 is known to inhibit MYC expression and its
transcriptional activity through targeted inhibition of the bro-
modomain protein BRD4, a key transcriptional regulator of MYC
expression26,27. In HCT116 cells, JQ1 showed concentration-
dependent inhibition of MYC expression, but had no effect on the
activated phosphorylation of AKT and ERK kinases (Fig. 3a).
Downregulation of MYC expression by JQ1 inhibited CRC cell
growth, and this inhibitory effect was synergistic when combined
treatment with spermidine in multiple CRC cell lines (Fig. 3b, c).
The synergistic growth inhibition was associated with marked
induction of apoptosis (Fig. 3d). Similar to spermidine treatment,
SMS deletion in combination with JQ1 also markedly inhibited
cell growth and induced apoptosis with enhanced activation of
caspase 3 and induction of cleaved PARP in both HCT116 and
DLD-1 cells (Fig. 3e–g), whereas restoration of SMS expression
significantly attenuated the growth inhibition in the SMS-KO
HCT116 cells treated with JQ1 (Fig. 3h). Consistent with the
mechanism of action for JQ1, silencing BRD4 that repressed MYC
expression or direct knockdown of MYC expression by shRNAs
also dramatically activated caspase 3 and suppressed cell growth
in SMS-KO HCT116 cells (Fig. 3i, j). Notably, SMS expression
was not affected by knockdown of either MYC or BRD4 in SMS-
WT cells (Fig. 3i). These findings indicate that SMS is not a
transcriptional target of MYC oncogene, but cooperate with MYC
to drive CRC cell growth and survival.
Co-repression of SMS and MYC markedly induces Bim
expression. To determine the molecular mechanism by which
SMS deletion in combination with MYC repression by
JQ1 synergistically induces apoptosis, we investigated a number
of proteins known to be involved in the regulation of apoptosis.
Strikingly, we found that the proapoptotic protein Bim28,
including all three isoforms (BimEL, BimL, and BimS), were
markedly upregulated by treatment with JQ1 in multiple SMS-KO
HCT116 and DLD-1 cell clones, whereas either depletion of SMS
in these clones or JQ1 treatment in multiple SMS-WT cell clones
resulted in moderate induction of the three Bim isoforms (Fig. 4a;
Supplementary Fig. 7a). Moreover, the marked induction of Bim
expression correlated with maximal activation of caspase 3 and
induction of cleaved PARP in the SMS-KO clones treated with
JQ1 (Fig. 3g; Supplementary Fig. 7a). Similar results were
observed in both HCT116 and patient-derived Pt130 primary
CRC29 cells with stable knockdown of SMS expression as well as
in SMS-defective SRS lymphoblastoid and fibroblasts (Supple-
mentary Fig. 7b–d). In contrast, expression of other proapoptotic
proteins (Bax, Bad, Bid, PUMA, and NOXA) and anti-apoptotic
proteins (XIAP, Mcl-1, and survivin) as well as the activated
phosphorylation of AKT and ERK kinases were unaffected by JQ1
treatment alone or in combination with SMS deletion in HCT116
cells (Fig. 4a). Although some anti-apoptotic proteins such as Bcl-
2 and Bcl-xL were slightly downregulated by JQ1, this down-
regulation was not further enhanced by SMS deletion (Fig. 4a).
Given that ODC is a transcriptional target ofMYC, JQ1 treatment
significantly inhibited ODC activity, resulting in a decrease in
putrescine levels, but had no effect on the levels of spermidine
and spermine in HCT116 cells (Supplementary Fig. 8a, b). In
addition, SMS KO-induced spermidine accumulation was also not
affected by JQ1 treatment (Supplementary Fig. 8b). Notably, the
ODC inhibitor DFMO, effectively inhibited ODC activity so as to
decrease both putrescine and spermidine levels, and lead to a
significant accumulation in G1 phase in HCT116 cells (Supple-
mentary Fig. 8a, c, d). However, unlike JQ1, DFMO inhibited Bim
expression and had no effect on apoptosis induction in HCT116
cells (Supplementary Fig. 8e, f). Moreover, DFMO did not further
enhance JQ1-induced G1 arrest and apoptosis, and showed no
synergistic growth inhibition in combination with JQ1 in
HCT116 cells (Supplementary Fig. 8d, f–h). Thus, these data
indicate that depletion of spermidine by DFMO and accumula-
tion of spermidine by SMS deletion respond differentially to MYC
repression by JQ1 on CRC cell growth and survival.
The marked induction of Bim protein expression by combina-
tion of JQ1 treatment and SMS deletion was associated with a
profound increase in the level of Bim mRNA expression as
determined by quantitative real-time (RT) PCR, but SMS KO or
JQ1 treatment alone only slightly induced expression of Bim
mRNA (Fig. 4b). These results suggest that SMS and MYC may
cooperate to regulate Bim transcriptional activity. Similar results
were observed by the combination treatment with spermidine and
JQ1 in both HCT116 and DLD-1 cells (Fig. 4c, d). Importantly,
silencing Bim dramatically prevented caspase 3 activation and
induction of apoptosis and reversed growth inhibition by JQ1
treatment in SMS-KO HCT116 cells (Fig. 4e–g). These effects,
however, were not observed by knockdown of PUMA expression
(Fig. 4g–i). Together, these findings reveal that the marked
induction of apoptosis by SMS deletion and JQ1 treatment in
CRC cells is largely mediated by Bim.
SMS deletion inhibits FOXO3a acetylation for Bim induction.
Bim is a well-characterized target gene of the transcription factor
FOXO3a30,31. The transcriptional function of FOXO3a is often
regulated by multiple post-translational modifications such as
phosphorylation and acetylation32. Both AKT-mediated phos-
phorylation and EP300 acetyltransferase-mediated acetylation of
FOXO3a can decrease its DNA-binding efficiency and subse-
quently lead to its translocation from the nucleus to the cyto-
plasm33–37. A recent study identifies spermidine as a direct EP300
inhibitor38. Therefore, we sought to determine whether Bim
alteration by SMS deletion is regulated by the post-
translationally-modified FOXO3a. We found that SMS KO did
not affect phosphorylation of AKT and its substrate FOXO3a in
both HCT116 and DLD-1 cells (Supplementary Fig. 9a). How-
ever, the acetylation of FOXO3a was dramatically inhibited in
these SMS-KO cells, which resulted in FOXO3a transport to the
nucleus and binding to Bim promoter to increase its transcrip-
tional activity (Fig. 5a–e). Conversely, re-expression of SMS in
SMS-KO HCT116 cells prevented the inhibition of FOXO3a
acetylation and resulted in FOXO3a nucleocytoplasmic transport
and repression of Bim promoter activity and protein expression
(Fig. 5f, g; Supplementary Fig. 9b–d). In contrast, addition of
putrescine or spermine in SMS-KO HCT116 cells did not reverse
the inhibitory effect on FOXO3a acetylation by SMS KO (Sup-
plementary Fig. 9b). However, exposure of HCT116 cells to
spermidine or knockdown of EP300 expression inhibited
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Fig. 3 Downregulation of both SMS and MYC synergistically induces apoptosis in CRC cells. a HCT116 cells were treated with the indicated
concentration of JQ1 for 24 h, followed by western blot analysis for the indicated proteins. b HCT116 cells were treated with JQ1 and spermidine (SPD),
alone or in combination, with the indicated concentrations for 72 h. Results are expressed as a percentage of viable cell number relative to the value
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control). d Apoptosis was assessed in HCT116 and DLD-1 cells treated for 72 h with 1 µM JQ1 and 1 mM SPD, alone or in combination, or with DMSO as
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FOXO3a acetylation and increased FOXO3a translocation to the
nucleus and binding to Bim promoter to activate Bim transcrip-
tion (Fig. 5h–m; Supplementary Fig. 10). Similar to SMS deletion
or treatment with spermidine (Fig. 4a, c), silencing EP300 also
increased Bim expression and caspase 3 activation, and these
effects were further enhanced by treatment with JQ1 (Fig. 5n).
Collectively, these data demonstrate that SMS deletion-induced
elevation of spermidine results in inhibition of EP300-mediated
FOXO3a acetylation, which in turn leads to FOXO3a transport to
the nucleus, and increases its binding to the Bim promoter to
stimulate Bim expression.
MYC-driven miR-19a and miR-19b co-repress Bim expression.
Although SMS deletion induced Bim expression via inhibition of
FOXO3a acetylation, the MYC function inhibitor JQ1 could
further enhance Bim induction at both the protein and mRNA
levels (Fig. 4a, b). These data suggest that MYC may also
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indicated p-values were determined by two-tailed unpaired t test in b, d, f, g and i, or one-way ANOVA test in g. Source data are provided as a Source
Data file.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-17067-x ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:3243 | https://doi.org/10.1038/s41467-020-17067-x | www.nature.com/naturecommunications 7
negatively regulate Bim expression through a mechanism distinct
from SMS. MYC has been shown to transcriptionally induce
expression of the miR-17-92 cluster, which is a single poly-
cistronic primary transcript that produces six mature microRNAs
(miRNAs): miR-17, miR-18a, miR-19a, miR-20a, miR-19b, and
miR-92a39 (Supplementary Fig. 11a). Several studies identified
Bim as a key miR-17-92 target gene40,41. We first used quanti-
tative RT-PCR to determine the effect of JQ1 treatment on the
levels of individual miR-17-92 components in CRC cells. As
shown in Fig. 6a, JQ1 effectively repressed expression of all
individual miR-17-92 components in HCT116 cells. As expected,
delivery of the miR-17-92 cluster that expressed all of the indi-
vidual miRNAs showed suppression of Bim expression in
HCT116 cells (Fig. 6b; Supplementary Fig. 11b). To determine
which individual members of miR-17-92 are specifically involved
in the regulation of Bim expression, we engineered a 12-
nucleotide seed mutation for individual miRNAs within miR-
17-92 to abolish the individual miRNA function with minimal
disruption to the overall gene structure42 (Supplementary Fig. 11a
and Table 1). The resulting miR-17-92 mutant with loss of both
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miR-19a and miR-19b functions was not able to inhibit Bim
expression as compared with wild-type miR-17-92 and its other
mutants (Fig. 6b). Furthermore, ectopic expression of both miR-
19a and miR-19b was required to maximally suppress Bim
expression, whereas expression of individual miR-17-92 members
had either no or a modest effect on Bim inhibition in HCT116
cells (Fig. 6c; Supplementary Fig. 11c, d). Reporter assays con-
firmed direct Bim 3′ untranslated region (UTR) inhibition
mediated by the predicted miR-19 binding site43 (Fig. 6d). These
data revealed that miR-19a and miR-19b are two major compo-
nents of miR-17-92 cluster in suppression of Bim expression in
HCT116 cells. Notably, expression of either miR-19a or miR-19b
showed a modest inhibition of Bim expression, and did not
attenuate JQ1-induced Bim expression (Fig. 6e). However,
expression of both miR-19a and miR-19b markedly repressed
Bim expression and almost completely prevented Bim upregula-
tion by JQ1 (Fig. 6e), indicating that both miR-19a and miR-19b
are required to mediate the effect of JQ1 on Bim expression.
Similar to the effect of JQ1, silencing MYC or BRD4 in HCT116
cells resulted in a significant decrease in the expression of both
miR-19a and miR-19b accompanied by an increase in Bim
expression (Fig. 6f–h). Conversely, ectopic expression of MYC
significantly increased the expression of both miR-19a and miR-
19b with a concomitant decrease in Bim expression, and pro-
foundly abrogated JQ1-induced miR-19a/b downregulation and
Bim expression (Fig. 6i–k). Moreover, Bim induction by silencing
MYC or BRD4 was further enhanced by SMS deletion in HCT116
cells at both the protein and mRNA levels (Fig. 6l, m). Taken
together, these findings highlight MYC as a key target of JQ1
responsible for its effect on Bim induction via regulation of miR-
19a/b expression. Furthermore, these data also indicate that MYC
and SMS cooperate to regulate Bim expression in CRC cells
through distinct pathways.
Co-repressing SMS and MYC expression causes tumor
regression. The marked induction of apoptosis associated with
CRC cell growth inhibition by SMS deletion in combination with
MYC repression by JQ1 in vitro suggests that targeting both SMS
and MYC signaling may be an effective strategy for CRC therapy.
To explore this possibility, nude mice bearing established SMS-
WT or SMS-KO HCT116 xenograft tumors were treated with JQ1
or vehicle control. Previous studies showed that treatment with
JQ1 at 50 mg/kg could effectively downregulate MYC expression
in multiple xenograft tumor models44,45. Administration of JQ1
with 50 mg/kg daily for 2 weeks slowed tumor growth in mice
with SMS-WT HCT116 xenografts without significant weight loss
(Fig. 7a, b). SMS deletion also showed a modest antitumor effect
(Fig. 7a). Neither SMS deletion nor JQ1 completed prevented
tumor growth. However, JQ1 in combination with SMS deletion
synergistically suppressed the growth of the tumor xenografts and
caused tumor regression (Fig. 7a). Western blot and IHC analyses
showed that JQ1 effectively inhibited MYC expression and
induced a modest increase in Bim expression with concomitant
inhibition of cell proliferation as measured by Ki67 and apoptosis
induction as measured by cleaved (activated) caspase 3 and PARP
(Fig. 7c–g). Similar to SMS KO-induced spermidine accumulation
as seen in vitro, SMS deletion also produced the excessive level of
spermidine in the xenograft tumors (Fig. 7h), which was asso-
ciated with a modest Bim induction and inhibition of cell pro-
liferation (Fig. 7c–f). However, SMS deletion in combination with
JQ1 treatment synergistically induced Bim expression and
apoptosis associated with tumor regression (Fig. 7a, c–g). Nota-
bly, silencing Bim, not PUMA, largely prevented the tumor
growth inhibition and caspase 3 activation by combination of
SMS deletion and JQ1 treatment (Fig. 7i, j). Similar observations
with profound antitumor effect and caspase 3 activation induced
by silencing SMS in combination with JQ1 treatment were found
in the Pt130 primary CRC xenograft model in which mice were
treated with doxycycline in drinking water for induction of SMS-
targeting shRNAs (Fig. 7k, l). Thus, these results confirm the
relevance of the tissue culture data to in vivo models, and
implicate Bim as a key target that mediates the synergistic anti-
tumor effect by combined inhibition of SMS and MYC signaling
pathways in CRC (Fig. 8).
Discussion
Polyamine biosynthesis is frequently dysregulated in human
cancers, and in particular, is associated with early-stage CRC
development12. Recent studies have brought polyamine metabo-
lism back to the limelight, providing a strong link between
polyamine metabolic pathway and oncogenic signaling pathways
in tumorigenesis1,2. In this study, we uncover an important
function of SMS in cooperation with MYC to repress Bim
expression through distinct regulatory pathways, and highlight
the downregulation of Bim as a key survival signal downstream of
oncogenic MYC and SMS signaling to facilitate CRC tumor
growth (Fig. 8).
Our study provides several insights into the biology and
therapeutic relevance of cooperative SMS and MYC signaling in
CRC tumorigenesis. First, our study suggests that overexpression
of SMS plays an important role in balancing cellular spermidine
levels that are a necessary adaptation for CRC tumorigenesis.
Polyamine homeostasis is tightly regulated in normal cells and
required for cell growth and tissue regeneration. Decreases in
tissue spermidine concentrations resulting from a decline in
polyamine biosynthesis occur with age in model organisms as
well as in humans46–49. In contrast, upregulation of the biosyn-
thetic activities of polyamine-producing enzymes such as ODC,
Fig. 5 SMS deletion induces Bim expression via inhibition of FOXO3a acetylation. a SMS-WT or SMS-KO HCT116 and DLD-1 cell lysates were
immunoprecipitated with FOXO3a antibody or IgG as control followed by western blot analysis for the indicated proteins. b Representative confocal images
of SMS-WT or SMS-KO HCT116 cells stained for FOXO3a (green) and DAPI (red). c The distribution of FOXO3a in the cytosol and nucleus shown in b was
analyzed using Image J. d ChIP analysis of SMS-WT or SMS-KO HCT116 cell extracts using a FOXO3a antibody or an irrelevant IgG. e Bim promoter activity
was assessed in SMS-WT or SMS-KO HCT116 cells. f, g SMS-KO HCT116 cells with re-expression of SMS or vector control were assessed by confocal
microscopy (f) for cellular staining of SMS (purple), FOXO3a (green), and DAPI (red), followed by quantification of FOXO3a distribution in the cytosol and
nucleus (g). h HCT116 cells with stable expression of two different sets of EP300 shRNAs or control shRNA were analyzed by western blot analysis for the
indicated proteins. i, j Cell lysates from HCT116 cells treated with 1 mM spermidine (SPD) or PBS for 24 h, or expressing EP300 shRNAs or control shRNA,
were immunoprecipitated with FOXO3a antibody or IgG as control, followed by western blot analysis for the indicated proteins (i), or by ChIP analysis (j)
of FOXO3a interaction with Bim promoter. k, l Bim promoter activity was analyzed in HCT116 cells treated with 1 mM SPD or PBS as control for 24 h (k), or
in HCT116 cells expressing EP300 shRNAs or control shRNA (l). m The expression levels of Bim mRNA in HCT116 cells expressing EP300 shRNAs or
control shRNA were quantified by RT-PCR analysis. n HCT116 cells expressing EP300 shRNAs or control shRNA were treated with 1 µM JQ1 or DMSO for
24 h, followed by western blot analysis for the indicated proteins. Scale bar, 25 µm. All graphic data are presented as mean values ±SEM (n= 3
independent experiments). The indicated p-values were determined by two-tailed unpaired t test. Source data are provided as a Source Data file.
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SRM, SAMDC, and SMS by oncogenic signaling results in
increased levels of polyamines, which are thought to play
important roles in the maintenance of the transformed phenotype
and tumor development2,3,18. However, excessive polyamine
accumulation can itself have major deleterious effects on cell
viability19,20,50. For instance, ODC-overproducing L1210 leu-
kemic cells produced a massive intracellular level of spermidine
that is cytotoxic independent of its oxidative metabolites51.
Conversely, reduction of spermidine levels by treatment with the
ODC inhibitor DFMO, attenuates apoptosis induced by different
cell death stimuli19,52. In addition, several studies have demon-
strated that spermidine production resulting from SRM expres-
sion or direct treatment with spermidine significantly suppress
cell growth in vitro and in vivo models of CRC53 and hepato-
cellular carcinoma54, which is likely mediated by induction of
autophagy through transcriptional and epigenetic regulation48,55.
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Similar to these findings, we found that SMS is overexpressed in
CRC throughout tumorigenesis, and target disruption of SMS
caused over-accumulation of spermidine that correlates with CRC
cell growth inhibition. This correlation is supported by our
findings that: (1) increased intracellular spermidine could inhibit
CRC cell growth in a concentration-dependent manner; and (2)
restoration of spermine or putrescine levels in SMS-deficient CRC
cells did not alter spermidine accumulation or reverse cell growth
inhibition by SMS deletion, but re-expression of SMS resulting in
a marked decrease in the spermidine level did restore cell growth.
In contrast to the detrimental consequence of elevated spermidine
in SMS-KO CRC cells, normal cells such as embryonic stem cells
and fibroblasts or skin fibroblasts lacking SMS grow at a normal
rate, although the spermidine levels are also increased in the
SMS-deficient normal cells24,25,56. These data suggest that normal
cells, with properly regulated polyamine homeostasis, can tolerate
a certain level of spermidine which is beneficial for their pro-
liferation. In CRC cells, however, the spermidine level is much
higher than in normal cells due to the upregulation of polyamine
biosynthetic enzymes from oncogenic signaling2,3,12. As such,
overexpression of SMS, converting spermidine to spermine, is
likely required to prevent the spermidine level from extending
beyond the toxic threshold, and still maintain a relatively high
level of spermidine favorable to support tumor growth. Thus,
genetic ablation of SMS completely inhibits SMS function and
induces excessive accumulation of spermidine, leading to growth
inhibition in CRC. Taken together, our findings highlight an
important role of SMS in spermidine homeostasis in CRC and
offer mechanistic insights into the cellular consequences of
spermidine imbalance in CRC tumorigenesis.
Second, our study reveals a cooperative link between SMS and
MYC signaling to maintain CRC cell survival through co-
repression of Bim expression. Loss-of-function mutations in SMS
gene result in SRS, an X-linked intellectual disability syndrome4,5.
However, the role of SMS in cancer is less characterized and
understood. As indicated above, our work suggests that SMS
overexpression is required to reduce spermidine level below the
cytotoxic threshold and support tumor growth in CRC. Analysis
of SMS expression at the mRNA or protein level (Fig. 1b–f)
associated with patients’ survival did not identify a significant
correlation between high SMS expression and short survival in
CRC. In subtype analysis by tumor stage (Supplementary Fig. 1a,
b) or cell differentiation status, we also did not detect significant
association between SMS expression and CRC prognosis. How-
ever, due to the small sample size used in our study, additional
large studies, particularly studies with subgroups for therapy
regimens and environmental-genetic interactions, are needed to
validate our findings. Aberrant expression of MYC is observed in
many human cancers including CRC11, but the prognostic value
of MYC in CRC remains debatable. A recent report using a meta-
analysis shows that MYC is not significantly associated with CRC
prognosis57. We found that MYC expression is significantly and
positively associated with SMS expression in CRC, although SMS
expression is not regulated by MYC. We divided CRC tissue
samples from the TCGA dataset (Supplementary Fig. 6b) in two
groups: high SMS/high MYC and low SMS/low MYC expression,
and performed a Kaplan–Meier survival analysis between two
groups. We found that CRC patients with high expression of both
SMS and MYC were not significantly associated with poor sur-
vival. Dysregulation of MYC is a consequence of mutations in
APC, a central hub in early colorectal carcinogenesis58. In a
mouse model of Min-Apc intestinal tumorigenesis, mice that
overexpressed SMS display similar colon tumor multiplicity and
size compared with multiple intestinal neoplasia as seen in the
Min mice59. Together, these data suggest that SMS alone does not
promote CRC tumorigenesis. Nevertheless, our data demon-
strated that SMS cooperates with MYC to maintain CRC cell
survival. Genetic and/or pharmacologic inhibition of either SMS
or MYC activity moderately suppressed CRC cell growth asso-
ciated with no or moderate induction of apoptosis. However,
combined inhibition of SMS and MYC signaling synergistically
repressed cell growth and induced apoptosis. This synergy results
from inhibition of the two parallel pathways that cooperate to
downregulate their common downstream target, the proapoptotic
protein Bim, through distinct regulatory mechanisms. We
showed that SMS blocks Bim transcription by reducing
spermidine-mediated inhibition of FOXO3a acetylation, whereas
MYC downregulates Bim expression post-transcriptionally by
inducing both miR-19a and miR-19b. Inhibition of either SMS or
MYC signaling pathway is insufficient to induce Bim expression,
but combined inhibition of both pathways is required for max-
imal induction of Bim expression and apoptosis in CRC cells.
Importantly, silencing Bim expression prevents apoptosis and
tumor growth in response to inhibition of both pathways. Thus,
the Bim protein integrates the survival signaling by SMS/sper-
midne/FOXO3a and MYC/miR-19a/b pathways in CRC cells.
Our findings indicate that inhibition of Bim function by activa-
tion of SMS and MYC signaling pathways plays a crucial role in
maintaining the transformed phenotype of CRC.
Third, our study suggests that concurrent inhibition of SMS
and MYC signaling is a promising therapeutic strategy for CRC.
The Cancer Genome Atlas data indicate that MYC-dependent
transcription is activated in nearly all CRC11, and thus, MYC is
an attractive therapeutic target for CRC. Although there is no
clear ligand-binding domain for targeting MYC, emerging evi-
dence demonstrate that small-molecule compounds such as JQ1,
which targets the bromodomain and extra-terminal domain
(BET) family epigenetic readers, act as alternative approaches to
inhibit MYC activity26,27. Nevertheless, the efficacy of BET
inhibitors in CRC is modest in general, suggesting that CRC
Fig. 6 MYC downregulates Bim expression by upregulation of miR-19a and miR-19b. a The expression levels of the indicated miRNAs were quantified by
RT-PCR analysis in HCT116 cells treated with 1 µM JQ1 or DMSO for 24 h. b, c Western blot analysis of HCT116 cells with stable expression of miR-17-92
and its mutants (b) or the indicated miRNAs (c) and their vector control. d HCT116 cells with stable expression of miR-19a/b or vector control were co-
transfected with a wild-type (WT) or mutant 19 (Mut19) human Bim 3′UTR reporter and an internal control Renilla-Luc. After 36 h, luciferase activities were
measured and normalized. The results are expressed as a percentage of the luc activity found in WT-transfected vector control cells. e HCT116 cells with
stable expression of miR-19a, miR-19b, miR-19a/b, or vector control were treated with 1 µM JQ1 or DMSO for 24 h, followed by western blot analysis for the
indicated proteins. f–h HCT116 cells with stable expression of two different sets of MYC shRNAs or BRD4 shRNAs, or control shRNA, were analyzed by
quantitative RT-PCR for expression of miR-19a (f) and miR-19b (g), or by western blot (h) for the indicated proteins. i–k HCT116 cells with stable
expression of HA-MYC and vector control were treated with 1 µM JQ1 or DMSO for 24 h, followed by western blot analysis (i) for the indicated proteins, or
by quantitative RT-PCR analysis for expression of miR-19a (j) and miR-19b (k). l, m SMS-WT or SMS-KO HCT116 cells with stable expression of MYC
shRNA, BRD4 shRNA, or control shRNA were analyzed by western blot for the indicated proteins (l), or by quantitative RT-PCR analysis for Bim mRNA
expression (m). All graphic data are presented as mean values ±SEM (n= 3 independent experiments). The indicated p-values were determined by two-
tailed unpaired t test. Source data are provided as a Source Data file.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-17067-x ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:3243 | https://doi.org/10.1038/s41467-020-17067-x | www.nature.com/naturecommunications 11
tumors are intrinsically resistance to BET inhibition. A recent
study showed that activation of the RAS/RAF/MAPK pathway is
a potential mechanism that mediates intrinsic resistance to JQ1 in
CRC cell cultures and xenograft models60. Here, we identify the
dysregulated polyamine biosynthetic enzyme SMS as a key factor
to alter the therapeutic response to JQ1 in CRC. Our data showed
that genetic deletion of SMS causes a reprograming of polyamine
metabolism with over-accumulation of spermidine, which sensi-
tizes CRC cells to JQ1 as demonstrated by the synergistic
induction of apoptosis and tumor regression. We revealed that
the synergistic antitumor effect by combined inhibition of SMS
and MYC signaling pathways is attributed to their mechanistic
convergences on the regulation of Bim expression, underscoring
the importance of apoptosis regulators in mediating the
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therapeutic response to CRC. Thus, the crosstalk between SMS
and MYC signaling appears to be an intrinsic phenotype of CRC.
Our findings indicate that SMS expression may serve as a pre-
dictive marker for MYC-targeted CRC therapies by using the BET
inhibitors. Several SMS inhibitors such as N-(3-aminopropyl)
cyclohexylamine, 5′-methylthioadenosine and decarboxylated S-
adenosylhomocysteine have been created, but these inhibitors
show little promise as a chemotherapeutic agent owing to the
limited potency and selectivity of the compounds, the slow
turnover of polyamines and the autoregulation of the polyamine
pathway1,61,62. Clinically effective SMS inhibitors remain to be
developed. Such SMS inhibitors in combination with BET inhi-
bitors may hold great promise in the treatment of CRC affected
by aberrations of both SMS and MYC-mediated signaling
pathways.
Methods
Cell lines, tissue samples, and chemicals. Human HCT116, DLD-1, HCT15, and
SW480 cell lines were obtained from the American Type Culture Collection
(ATCC). HCT116 cells were cultured in McCoy’s medium (Sigma). DLD-1 and
HCT15 cells were cultured in RPMI-1640 medium (Sigma). SW480 cells and
patient-derived Pt130 primary CRC cells29 were cultured in DMEM medium
(Sigma). All media were supplemented with 10% FBS (Sigma), streptomycin (100
µgml−1) and penicillin (100 unitsml−1). In experiments with addition of poly-
amines to the cultures, 1 mM aminoguanidine was included in the medium to
inhibit amine oxidase present in the serum51. All cell lines were subjected to regular
mycoplasma testing via PCR using e-Myco Plus kit (iNtRON Biotechnology) and
underwent short tandem repeat (STR) profiling (Genetica). The SRS lympho-
blastoid (3811) and fibroblast (CMS1850B, CMS25081A) cell lines and their
control cell lines (CMS25378, CMS25400A) were derived from three SRS patients
and two healthy male donors. The SRS lymphoblastoid cells were grown in RPMI-
1640 medium supplemented with 15% FBS, streptomycin (100 µgml−1) and
penicillin (100 unitsml−1). The SRS fibroblast cells were grown in DMEM medium
supplemented with 10% FBS, 1% sodium pyruvate, 1% non-essential amino acids,
streptomycin (100 µgml-1) and penicillin (100 unitsml−1). The primary colon
tumors and adjacent normal control tissues were collected with informed consent
from patients (pt2893, pt2405, pt2769, pt2647, pt2751, and pt2293) who had
undergone surgery resections at the University of Kentucky Markey Cancer Center.
Data regarding the CRC stage and pathology status are listed in Supplementary
Fig. 1c. Experiments were performed under a protocol approved by the University
of Kentucky Institutional Review Board. JQ1 was purchased from MedChem
Express. Putrescine (P5780), spermidine (S2626), spermine (S4264), DFMO
(D193), aminoguanidine (#396494) and (2-Hydroxypropyl)-β-cyclodextrin (H107)
were obtained from Sigma.
Plasmids and transfection. The human SMS was amplified by PCR using a
HCT116 cDNA library, and then subcloned into the pLenti6.3 vector63. The
human Bim promoter (position −763/+29)31 was amplified from HCT116 geno-
mic DNAs, and then cloned into the pGL3 basic reporter vector that contains
firefly luciferase (Promega). The human Bim 3′UTR WT fragment as reported43
was amplified from a HCT116 cDNA library, and then inserted into a region
immediately downstream of the firefly luciferase gene in pGL3 control reporter
vector (Promega). The Bim 3′UTR mutant was generated using the QuikChange
XLII site-directed mutagenesis kit (Stratagene). The pcDNA3-HA-MYC (#74164),
MSCV-mir-17-92 (#64100), MSCV-miR-18a (#64228), MSCV-miR19a/b (#24827),
MSCV-miR-19b (#23275), MSCV-miR-20a (#24709), and MSCV-miR-92a
(#64092) were purchased from Addgene. The miR-17 or miR-19a fragment was
amplified using the MSCV-miR-17-92 or MSCV-miR19a/b as a template respec-
tively, and then cloned into the MSCV vector. The miR-17-92Mut17, miR-17-
92Mut18a, miR-17-92Mut19a, miR-17-92Mut19b, miR-17-92Mut19a/b, miR-17-
92Mut20a, and miR-17-92Mut92a were generated using the QuikChange XLII site-
directed mutagenesis kit. The loss of miR-17, miR-18a, miR-19a, miR-19b, miR-
20a or miR-92a expression and the intact expression level of the remaining miR-
17-92 components were validated using the TaqMan MicorRNA assays (4427975,
Applied Biosystems). All primers used are listed in Supplementary Table 1. All
sequences were verified by automated DNA sequencing. For transient expression of
SMS, cells were infected with lentivirus for 48 h using the pLenti6.3-SMS plasmid.
For stable expression of MYC, cells were transfected with pcDNA3-HA-MYC using
Lipofectamine 3000 according to the manufacturer’s protocol (Thermo Fisher
Scientific), followed by selection with G418 (500 µgml−1) for 10 days.
Gene silencing by shRNA. The lentiviral shRNAs against human SMS, Bim,
PUMA, EP300, MYC, and BRD4 were cloned into pLKO.1 or Tet-pLKO.1 vector
(Addgene), and their sequences are listed in Supplementary Table 2. The Non-
Target control shRNA (SHC002) was from Sigma. To establish stable transfectants
with knockdown of specific protein expression, cells were infected with lentivirus
using the indicated shRNA constructs followed by selection with puromycin (2
µgml−1, for SMS and EP300 shRNAs) or hygromycin (250 µgml−1, for Bim,
PUMA, MYC, and BRD4 shRNAs) for 7–10 days63.
Generation of human SMS KO cell lines. A short guide RNA, 5′-GATACTGGCC
CACCGCCGAC-3′, was designed to target exon 5 of human SMS using the
CRISPR designing tool21 (https://zlab.bio/guide-design-resources). The gRNA was
cloned into the Cas9-encoding PX459 vector (#62988, Addgene), and transiently
transfected into the cells using Lipofectamine 3000. For SMS WT, cells were
transfected with non gRNA-Cas9-encoding pX459 vector. Single cells were selected
by serial dilution followed by puromycin (2 µgml−1) treatment for one week. Single
cell colonies were screened for internal deletion or insertion by sequencing the PCR
Fig. 7 Silencing SMS in combination with JQ1 markedly suppress CRC tumor growth. a, b Mice bearing SMS-WT or SMS-KO HCT116 xenograft tumors
were treated daily with vehicle or JQ1 at 50mgkg−1. The tumor volume (a) and body weight (b) are presented as mean values ±SEM (n= 6 mice/group).
c, d Representative tumors from mice euthanized 6 h after the final treatment with JQ1 or vehicle control as in a were analyzed by western blot (c) for the
indicated proteins, or by H&E staining and IHC staining (d) for the indicated proteins. Scale bar, 30 µm. e–g Bim (e), Ki67 (f), and Act-caspase 3 (g)
positive cells shown in d were quantified using Image J. The results are presented as the mean percentage of the positive cells ±SEM (n= 6 mice/group).
h The levels of putrescine (PUT), spermidine (SPD), and spermine (SPM) in the tumors from mice (n= 6 mice/group) euthanized 6 h after the final
treatment with JQ1 or vehicle control as in a were determined by LC-MS. i Mice bearing SMS-WT or SMS-KO HCT116 xenograft tumors with stable
expression of Bim shRNA or PUMA shRNA were treated daily with vehicle or JQ1 at 50mgkg−1. The tumor volume was presented as mean values ±SEM
(n= 6 mice/group). j Representative tumors from mice euthanized 6 h after the final treatment with JQ1 or vehicle control as in i were analyzed by western
blot. k Mice bearing Pt130 xenograft tumors expressing tet-inducible SMS shRNA were maintained with or without doxycycline (Dox, 0.5 mgml−1) in the
drinking water and treated daily with vehicle or JQ1 at 50mgkg−1. Dox was given to mice until the JQ1 treatment was completed. The tumor volume was
presented as mean values ±SEM (n= 6 mice/group). l Representative tumors from mice euthanized 6 h after the final treatment with JQ1 and Dox, alone
and in combination, as in k were analyzed by western blot. The indicated p-values were determined by two-tailed unpaired t test in a, e–i, and k, or one-way
ANOVA test in b. Source data are provided as a Source Data file.
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fragments using the following primers: 5′-AGGGAAATGCAGTGTATGAGC-3′
(forward) and 5′-AGAGGGACAAAGTGGACTGG-3′ (reverse).
Measurement of intracellular polyamines. Polyamines were extracted according
to the protocol described by Byun et al.64 with some modifications. Cell pellets
were reconstituted in 100 µl of 0.04% heptafluorobutyric acid, and 100 µl of d20-
spermine (1.6 µM) was added as an internal standard. Protein was precipitated and
the supernatant was collected and adjusted to pH 9.0 by adding sodium carbonate
buffer. Derivatization of amine was performed by adding 50 µL of isobutyl chlor-
oformate followed by incubating at 35°C for 15 min. After cooling, the solution was
extracted with 4 mL of ethyl acetate, and the organic solvent was evaporated under
a gentle steam of nitrogen at room temperature. The residue was reconstituted
using 100 µl of methanol-water (50:50, v/v) solution, and a 2-µl aliquot was injected
into the LC-MS system with an Ultimate 3000 ultra-high performance liquid
chromatography and a Q-exactive mass spectrometer (Thermo Fisher Scientific).
Separation was performed on a Kinetex C18 reversed-phase column (2.6 mm ×
100 mm, 2.1 μm) with gradient elution (A, 0.1% formic acid; B, 0.1% formic acid in
acetonitrile). Mass spectrometric detection was performed by electrospray ioniza-
tion in positive mode with source voltage maintained at 4.3 kV. The concentrations
of polyamines were calculated based on the LC-MS peak area ratios of analytes to
d20-spermine. Levels of polyamines were normalized to protein amount.
Quantitative RT-PCR analysis. Total cellular RNA was isolated using the RNeasy
plus mini kit (Qiagen). Equal amounts of RNA were used as templates for all
reactions. cDNA was generated with the SuperScript III First Strand Synthesis
System (Invitrogen). RT-PCR was performed with a StepOne RT-PCR system
(Applied Biosystems) using Maxima SYBR Green/ROX qPCR Master Mix
(Thermo Fisher Scientific). The PCR primers used are: Bim, 5′-CTCGGACTGA-
GAAACGCAAG-3′ (forward) and 5′-CGCAGGCTGCAATTGTCTAC-3′
(reverse); GAPDH, 5′-ACAACTTTGGTATCGTGGAAGG-3′ (forward) and 5′-
GCCATCACGCCACAGTTTC-3′ (reverse). GAPDH was used as an internal
control for normalization, and the relative expression level was calculated by the
comparative CT (ΔΔCT) method. For quantification of miRNA expression, the
miRNAs were isolated using the mirVana miRNA isolation kit (Thermo Fisher
Scientific). TaqMan probes (#4427975) were used according to the manufacture’s
protocol (Applied Biosystems) and the CT values were normalized to U6. Each
experiment was performed in triplicate and repeated at least three times.
Luciferase reporter assay. Cells (1 × 105) were co-transfected with 0.3 µg of the
Bim promoter reporter, Bim 3′UTR reporter or Bim 3′UTR mutant reporter
together with 0.03 µg of pHRL-TK Renilla luciferase control vector using Lipo-
fectamine 3000. Thirty-six hours post-transfection, firefly and Renilla luciferase
activities were measured using a dual-luciferase assay kit (Promega). The firefly
luciferase activity for each sample was normalized based on transfection efficiency
as determined by Renilla luciferase activity. Each experiment was performed in
triplicate and repeated at least three times.
ChIP assay. ChIP analysis was performed according to the protocol described by
Nowak et al.65 with some modifications. Cells (5 × 106) were cross-linked with 1%
formaldehyde for 15 min at room temperature, then lysed in L1 buffer (50 mM
Tris-HCl, pH 8.0, 2 mM EDTA, 0.1% IGEPAL, 10% glycerol, 1 mM dithiothreitol,
1 mM phenylmethylsulfonyl fluoride and protease inhibitor cocktail) on ice. Nuclei
were pelleted by centrifugation and resuspended in ChIP lysis buffer (50 mM Tris-
HCl, pH 8.0, 10 mM EDTA, 1% SDS). Chromatin was subjected to sonication and
then immunoprecipitated with FOXO3a antibody (sc-48348, Santa Cruz Bio-
technology) or an irrelevant immunoglobulin G (IgG) overnight, followed by
incubation with a 50% slurry of protein G sepharose/salmon sperm DNA (Thermo
Fisher Scientific) for 3 h at 4 °C. Bound DNA–protein complexes were eluted, and
crosslinks were reversed after a series of washes. Purified DNA was resuspended in
TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA) for PCR analysis. The primers
used for Bim promoter are 5′-TACTCCGGTAAACACGCCAG-3′ (forward) and
5′-CGGAGCGAAGTGAAACCTG-3′ (reverse).
Immunoprecipitation and western blot analysis. Cells were lysed in NP-40 lysis
buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 10%
glycerol, protease, and phosphatase inhibitor cocktail). Protein concentrations were
measured using the BCA protein assay reagent (Thermo Fisher Scientific). The cell
lysates (500 µg protein) were immunoprecipitated with FOXO3a antibody (#12829,
Cell Signaling Technology) overnight followed by incubation with a 50% slurry of
protein G sepharose beads for 3 h at 4 °C. The beads were washed three times with
the lysis buffer, and the immunoprecipitated protein complexes were resuspended
in 2× Laemmli sample buffer followed by western blot analysis. For western blot
analysis, equal amounts of protein were resolved by SDS-PAGE, transferred to
PVDF membranes, immunoblotted with specific primary and secondary anti-
bodies, and detected using chemiluminescence (GE Healthcare). A list of all
antibodies used in this work and dilutions can be found in Supplementary Table 3.
Contrast of western blot images was adjusted using Adobe Photoshop and
uncropped and unprocessed scans are found in the Source Data file.
ODC activity assay. ODC activity was measured as release of CO2 from L-[1-C14]
ornithine52. Cells were lysed in ODC lysis buffer (25 mM Tris-HCl, pH 7.5, 1 mM
EDTA, 1 mM DTT, 0.1% Triton X-100, protease, and phosphatase inhibitor
cocktail). Protein concentrations were measured using the BCA protein assay
reagent (Thermo Fisher Scientific). Cell lysates (100 µg protein) were incubated at
37 °C for 1 h after addition of 0.5 μCi L-[1-C14] ornithine hydrochloride (Moravek)
and 100 mM Tris-HCl buffer (pH 7.5) containing 0.4 mM L-ornithine, 0.4 mM
pyridoxal phosphate, 1 mM EDTA, and 4 mM DTT. Released CO2 was captured
with a 3-MM chromatography paper (Thermo Fisher Scientific), which was soaked
with 50 µl SOLVABLE (PerkinElmer) and put on the top of a glass tube and closed
with rubber cap. Reactions were terminated by addition of 2M citric acid. The 3-
MM paper was transferred to a scintillation vial, and 5 mL scintillation fluid were
added. Liquid scintillation radioactivity was measured by scintillation counter
(LS6500, Beckman Coulter). ODC activity was determined as picomoles of CO2
released (cpm) per milligram of protein per hour.
Cell viability assay. Cells (5 × 104/well) were seeded in six-well plates in triplicate.
After 24 h, cells were treated with the indicated drugs and incubated at 37 °C. The
cells were cultured for 3 days and the number of viable cells was counted using the
Vi-CELL XR 2.06 (Beckman Coulter). For the combination studies, the synergy was
assessed using the combination index (CI) according to the Chou-Talalay
method66 using CompuSyn software (version 1.0.1). Generally, CI values of <1 are
taken to indicate synergistic interaction between drugs, and CI values of > 1
indicate no interaction (drug antagonism). Each experiment was performed in
triplicate and repeated at least three times.
3D cell culture. Cell suspension (3 × 104/250 μl) in the appropriate medium was
seeded on top of a thin layer of Matrigel (BD Biosciences) in 24-well plates, and
incubated at 37 °C for 30 min, followed by the addition of 250 μl medium con-
taining 10% Matrigel (BD Biosciences) over the cell suspension. The medium was
changed every 2 days. Cell spheres were photographed using a Nikon Eclipse Ti-E
inverted microscope. The sphere sizes from 50 randomly chosen spheroids were
measured using Nikon NIS-Elements AR software (version 5.00.00).
Cell cycle and apoptosis analysis. Cells were plated in 100-mm dishes. After 24 h,
cells were treated as indicated in the figure legends. Both adherent and floating cells
were harvested. For cell-cycle analysis, cell nuclei were prepared and stained with
ethidium bromide63. Cell cycle phase distribution was determined by flow cyto-
metry. For apoptosis, cells were analyzed by flow cytometry using the FITC
Annexin V Apoptosis Detection Kit according to the manufacturer’s protocol
(Thermo Fisher Scientific). The flow cytometry gating strategies are shown in
Supplementary Fig. 12.
Immunofluorescence. Cells (5 × 104) grown on coverslips were fixed with 4%
paraformaldehyde in PBS for 15 min, permeabilized in 0.2% Triton X-100 and
0.5% BSA in PBS for 5 min and then blocked with 4% BSA in PBS for 10 min. The
cells were incubated overnight at 4 °C with the indicated primary antibody. After
three washes with 0.05% Triton X-100 in PBS, cells were incubated with the
indicated secondary antibody for 1 h. Cells were then washed three times, mounted
with DAPI containing mounting medium (H-1200, Vector Laboratories), viewed
and photographed with a Nikon A1+-Ti2 confocal microscope. For the study of
FOXO3a distribution in cells, the intensities of FOXO3a in nucleus and whole cells
(n= 30) were quantified separately by Image J (version 1.8.0). The levels of
FOXO3a in the cytosol were calculated by subtracting the levels of nuclear
FOXO3a from that of whole cells. The Primary and secondary antibodies used in
this assay are listed in Supplementary Table 3.
IHC staining. The CRC tissue microarrays were established by the Biospecimen
Procurement and Translational Pathology Shared Resource Facility of the Uni-
versity of Kentucky Markey Cancer Center, and contain 57 pairs of tumor and
adjacent normal control tissues collected from patients with CRC who had
undergone surgery resections at the Markey Cancer Center. Tissue sections were
deparaffinized, rehydrated, and treated with hydrogen peroxide. Antigen retrieval
was performed using citrate buffer (pH 6.0) in a steamer. Tissue sections were first
blocked with avidin, biotin, and 5% normal goat serum and then incubated in a
humidified chamber at 4 °C overnight with antibodies as indicated in Supple-
mentary Table 3. The samples were then incubated with biotin-labeled goat anti-
rabbit secondary antibody and subsequently with horseradish peroxidase-avidin
complex (Vector Laboratories). Antibody-associated staining was visualized using
diaminobenzidine substrate solution and the tissue sections were then counter-
stained with hematoxylin. The immunoreactivity was scored blindly according to
the value of immunoreaction intensity (none= 0; weak= 1; intermediate= 2; and
strong= 3) and the percentage of tumor cell stained (none= 0; <10%= 1; 10–50%
= 2; >50%= 3) using a semi-quantitative seven-tier system63. The intensity and
percentage values were added to provide a final immunoreactivity score ranging
from 0 to 6.
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Animal studies. Male and female athymic nude mice (5–6 weeks old) were pur-
chased from Taconic, and maintained and treated under AAALAC-accredited
specific pathogen-free housing vivarium and care, and veterinary supervision fol-
lowing standard guidelines for temperature and humidity with 12/12 light cycle.
Experiments were carried out under a protocol approved by the University of
Kentucky Institutional Animal Care and Use Committee. Xenograft tumors were
established by subcutaneously injecting CRC cells (2 × 106/mouse for HCT116; 1 ×
107/mouse for Pt130) in a 1:1 mixture of media and Matrigel (BD Biosciences).
Mice were randomized among control and treated groups (n= 6/group) when
tumors were well-established (~160 mm3). JQ1 was first dissolved in DMSO and
diluted to 9 vol of 10% β-cyclodextrin in sterile saline, and administrated through
intraperitoneal injection60. Mice bearing xenograft tumors were treated daily with
vehicle or JQ1 at 50 mgkg−1. For tet-inducible SMS shRNA expression, mice
received doxycycline (0.5 mgml−1) in the drinking water67. Tumor dimensions
were measured using a caliper. The tumor volumes were calculated as mm3= π/
6 × larger diameter (smaller diameter)2. A small portion of xenograft tumors were
fixed overnight in paraformaldehyde followed by dehydration in graded ethanol
and embedding in paraffin. Tissue sections were prepared for hematoxylin and
eosin (H&E), SMS, Bim, Ki67, and activated caspase 3 staining. The remaining
tumors were homogenized in 2% SDS lysis buffer and then processed for western
blot analysis63.
Bioinformatics and statistical analyses. Three datasets were used to determine
the relative expression levels of SMS and MYC genes in human CRC patients. The
Cancer Genome Atlas (TCGA) dataset, TCGA-COAD, contains 461 tumor sam-
ples and 41 matched normal samples. The Skrzypczak dataset contains 81 tumors
and 24 normal samples. The Gaedcke dataset contains 65 matched pairs of tumor
and normal samples. Expression of SMS andMYC in tumor versus normal samples
was compared on the basis of two-tailed two-sample t-tests when all tumor and
normal samples are from different individuals or linear mixed models when there
are matched pairs of tumor and normal samples from the same individual. All
statistical analyses for gene expression were performed using R (version 3.4.1).
Statistical analysis for each experiment were performed as described in the
corresponding figure legends. Data between groups were compared using a two-
tailed unpaired t test, one-way ANOVA test, χ2-test or Spearman’s rank-order
correlation test. All data are presented as mean ± SEM. Differences between groups
were considered statistically significant at p < 0.05. GraphPad Prism (version 8.1.1)
software were used for these analyses. Unless otherwise stated, the experiments
were performed at least three times with similar results. IHC staining and animal
experiment were performed for a single time with biological replicates indicated in
the figure legend and Methods section. Western blot and ChIP analyses were
performed two times with similar results.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The TCGA Colon Adenocarcinoma (TCGA-COAD) mRNA-sequencing data referenced
during the study are available in a public repository from the GDC Data Portal (https://
portal.gdc.cancer.gov/projects/TCGA-COAD). The raw microarray RNA-sequencing
data “Skrzypczak Colorectal” and “Gaedcke Colorectal” are available from Gene
Expression Omnibus (https://www.ncbi.nlm.nih.gov/gds/) with accession GSE20916 and
GSE20842, respectively. The corresponding processed and normalized data are available
from Oncomine (https://www.oncomine.org/). The source data underlying Figs. 1b–d,
f–h, 2a–c, e–k, 3a, b, d–j, 4, 5a, c–e, g–n, 6, and 7a–c, e–l and Supplementary Figs. 1a, b,
2a, b, d, 3b–d, 4a–c, e, f, 5–7, 8a–g, 9, 10b, and 11b–d are provided as a Source Data file.
All the other data supporting the findings of this study are available within the article and
its supplementary information files and from the corresponding author upon reasonable
request. A reporting summary for this article is available as a Supplementary
Information file.
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